9/10/2026
Rhelion Life Sciences launches stability program for ibogaine
Filament Health begins stability testing for IBEX011, a botanical ibogaine drug.
Topic archive
regulation
9 stories
9/10/2026
Rhelion Life Sciences launches ibogaine stability program
Filament Health begins stability program for IBEX011 amid rising ibogaine demand.
9/4/2026
Federal report urges states to prepare for psychedelics
States advised to anticipate FDA approval of psychedelics for medical use.
8/26/2026
Psychedelic tourism raises safety concerns
Recent deaths highlight risks in unregulated psychedelic retreats.
8/26/2026
Americans face risks at overseas psychedelic clinics
Ibogaine treatments in Mexico raise safety concerns for U.S. patients.
8/16/2026
Ibogaine shows promise for treating brain disorders
Research highlights ibogaine's potential in opioid addiction and multiple sclerosis.
8/7/2026
Ibogaine treatment explored for veterans
Ibogaine's potential in treating PTSD and opioid addiction in veterans examined.
7/24/2026
Ibogaine may gain U.S. access under Trump administration
The Trump administration considers making ibogaine available for therapeutic use.
7/23/2026
McCaul supports NDAA amendment for veteran ibogaine access
The amendment aims to expand treatment options for PTSD and addiction.